DJ Corbus Pharmaceuticals Holdings Inc. Stock Rises Wednesday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ rallied 1.34% to $9.84 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.80% to 22,635.00 and the Dow Jones Industrial Average rising 2.85% to 47,909.92.
The stock's rise snapped a two-day losing streak.
Corbus Pharmaceuticals Holdings Inc. closed 52.14% below its 52-week high of $20.56, which the company reached on October 20th.
The stock outperformed some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 2.15% to $7.29, Fortress Biotech Inc. (FBIO) fell 1.70% to $2.31, and Viking Therapeutics Inc. (VKTX) fell 0.09% to $33.67.
Trading volume (203,897) eclipsed its 50-day average volume of 198,991.
Data source: Dow Jones Market Data, FactSet. Data compiled April 8, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 08, 2026 17:19 ET (21:19 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments